DavidLuisRamirezMD

Physician

Dr. Ramirez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Fax+1 916-734-7946

University of California Davis HealthFellowship, Hematology and Medical Oncology, 2006 - 2009
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2003 - 2006
Boston University School of MedicineClass of 2003

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

PubMed

Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2- breast cancer.
Akshara Singareeka Raghavendra, Nicole M Kettner, Danielle Kwiatkowski, Senthil Damodaran, Yan Wang
NPJ Breast Cancer. 2025-01-26
1 citations
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 Trial.
Jay P Reddy, Alexander D Sherry, Bryan Fellman, Suyu Liu, Tharakeswara Bathala
International Journal of Radiation Oncology, Biology, Physics. 2024-10-30
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.
Clinton Yam, Miral Patel, Holly A Hill, Ryan Sun, Roland L Bassett Jr
Cancer Research Communications. 2024-10-01

Breast Cancer Survivor: Don’t Put off Your MammogramJuly 25th, 2022
Breast Cancer Survivor: Don’t Let COVID-19 Keep You from Getting Your MammogramJuly 14th, 2020
Stage III Triple-Negative Breast Cancer Survivor Encourages Breast AwarenessJanuary 29th, 2019
Join now to see all